EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dendrobium officinale polysaccharide ameliorates polycystic ovary syndrome by modulating the MAPK/ERK signaling pathway

Xueyu Qin, Yongyan Lu, Peng Zeng, Guanyou Huang, Heng Luo, Shuyun Zhao

Frontiers in Pharmacology · 21.08.2026 · 17

DOI: 10.3389/fphar.2026.1786264 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 21.08.2026. Verfasst von Xueyu Qin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Guizhou Medical University Clinical Medical College, Guiyang, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Polycystic ovary syndrome (PCOS) is one of the most common endocrine and metabolic disorders affecting women of reproductive age. Dendrobium officinale polysaccharides (DOP) have shown multiple pharmacological activities, but their therapeutic effects and underlying mechanisms in PCOS remain incompletely understood.

Methods

A dehydroepiandrosterone (DHEA)-induced mouse model of PCOS was established to evaluate the effects of DOP. Estrous cyclicity, ovarian histopathology, serum hormone levels, RT-qPCR, and Western blot analyses were performed to assess reproductive function, endocrine changes, and MAPK/ERK-related signaling.

Results

DOP treatment restored estrous cyclicity, improved ovarian morphology, and partially normalized serum luteinizing hormone, follicle-stimulating hormone, and testosterone levels. In addition, DOP reduced ERK1/2 phosphorylation and downregulated the expression of CYP17A1 and CYP19A1.

Conclusion

DOP ameliorated reproductive and endocrine abnormalities in a DHEA-induced mouse model of PCOS. The findings suggest that modulation of MAPK/ERK signaling may contribute to the biological effects of DOP, although further mechanistic studies are required to establish causal relationships.

Schlagwörter

Stichwörter der Autor:innen

Dendrobium officinaleMAPK/ERK signaling pathwayovarian functionpolycystic ovary syndrometraditional Chinese medicine

Autor:innen und Institutionen

  • Guizhou Medical University Clinical Medical College, Guiyang, China.
  • Gynecology Department, Anshun People's Hospital, Anshun, China.
  • Guizhou Natural Products Research Center, Guiyang, China.

Zitieren

APA

Qin, X., Lu, Y., Zeng, P., Huang, G., Luo, H., & Zhao, S. (2026). Dendrobium officinale polysaccharide ameliorates polycystic ovary syndrome by modulating the MAPK/ERK signaling pathway. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1786264

Vancouver

Qin X, Lu Y, Zeng P, Huang G, Luo H, Zhao S. Dendrobium officinale polysaccharide ameliorates polycystic ovary syndrome by modulating the MAPK/ERK signaling pathway. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1786264

BibTeX
@article{Qin2026,
  author = {Qin, Xueyu and Lu, Yongyan and Zeng, Peng and Huang, Guanyou and Luo, Heng and Zhao, Shuyun},
  title = {Dendrobium officinale polysaccharide ameliorates polycystic ovary syndrome by modulating the MAPK/ERK signaling pathway},
  journal = {Frontiers in Pharmacology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fphar.2026.1786264}
}
Kostenlos starten →